This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Isobe, M. Articles by Haber, E. Search for Related Content PubMed PubMed Citation Articles by Isobe, M. Articles by Haber, E.

Circulation, Vol 85, 738-746, Copyright © 1992 by American Heart Association

ARTICLES

Imaging the rejecting heart. In vivo detection of major histocompatibility complex class II antigen induction

M Isobe, J Narula, JF Southern, HW Strauss, BA Khaw and E Haber
Cardiac Unit, Massachusetts General Hospital, Boston 02114.

BACKGROUND. Mice with abdominal heterotopic heart transplants were studied to determine whether scintigraphic detection of an increase in major histocompatibility complex (MHC) class II antigen expression could be used as a noninvasive method for diagnosing early rejection. METHODS AND RESULTS. Allografts from C3H/He (H2k) donors were transplanted into BALB/c (H2d) recipients (n = 18). Two of the 18 allografted mice were treated with cyclosporine (15 mg/kg/day), and two isografted mice served as controls. Each mouse was injected intravenously with 100 microCi of 111In-labeled anti-MHC class II monoclonal antibodies (10-2-16 and 14-4-4S) 24 hours before scintigraphy. After imaging, the mice were killed for tissue counting and histopathology. Radiotracer uptake in the grafts reflected the severity of rejection as determined by histopathological criteria. The percent injected dose per gram of tissue in excised grafts was 4.8 +/- 1.8 (mean +/- SD) for normal grafts (n = 8), 11.1 +/- 9.7 for grafts with grade IA rejection (n = 3, NS), 18.0 +/- 3.8 for grafts with grade IIIA rejection (n = 4, p less than 0.001 versus normal), 18.7 +/- 3.2 for grafts with grade IIIB rejection (n = 3, p less than 0.001 versus normal), and 22.6 +/- 5.4 for grafts with severe rejection (grade IV) (n = 3, p less than 0.001 versus normal). Rejecting allografts with lymphocyte infiltration but without significant myocyte necrosis could be identified by this scintigraphic method. In the BALB/c donor-C57BL/6 (H2b, IE-) recipient combination, rejecting allografts were visualized by 14-4-4S (anti-IEk,d,p,r) antibody but not by 10-2-16 (anti- IAk,r,s,f) antibody. This difference shows that class II antigens induced on donor hearts are solely responsible for the antibody uptake in positive scintigrams of rejecting allografts. CONCLUSIONS. We conclude that 111In-labeled anti-MHC class II antigen antibody imaging is a sensitive and noninvasive method for detecting cardiac allograft rejection.

This article has been cited by other articles:

				M. Isobe, H. Kosuge, and J.-i. Suzuki T Cell Costimulation in the Development of Cardiac Allograft Vasculopathy: Potential Targets for Therapeutic Interventions Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1447 - 1456. [Abstract] [Full Text] [PDF]

				Y. Chen, Y. Demir, A. Valujskikh, and P. S. Heeger Antigen Location Contributes to the Pathological Features of a Transplanted Heart Graft Am. J. Pathol., April 1, 2004; 164(4): 1407 - 1415. [Abstract] [Full Text] [PDF]

				K. Tsukioka, J.-i. Suzuki, M. Fujimori, Y. Wada, K. Yamaura, K.-i. Ito, R. Morishita, Y. Kaneda, M. Isobe, and J. Amano Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection Cardiovasc Res, December 1, 2002; 56(3): 472 - 478. [Abstract] [Full Text] [PDF]

				J.-i. Suzuki, M. Isobe, S. Yamazaki, S. Horie, Y. Okubo, and M. Sekiguchi Sensitive diagnosis of cardiac allograft rejection by detection of cytokine transcription in situ Cardiovasc Res, November 1, 1998; 40(2): 307 - 313. [Abstract] [Full Text] [PDF]

				M. Isobe, J.-i. Suzuki, S. Yamazaki, Y. Yazaki, S. Horie, Y. Okubo, K. Maemura, Y. Yazaki, and M. Sekiguchi Regulation by Differential Development of Th1 and Th2 Cells in Peripheral Tolerance to Cardiac Allograft Induced by Blocking ICAM-1/LFA-1 Adhesion Circulation, October 7, 1997; 96(7): 2247 - 2253. [Abstract] [Full Text]

				A. I. McGhie, B. Radovancevic, P. Capek, W. H. Moore, L. Kasi, L. Lamki, F. J. Clubb Jr, O. H. Frazier, and J. T. Willerson Major Histocompatibility Complex Class II Antigen Expression in Rejecting Cardiac Allografts : Detection Using In Vivo Imaging With Radiolabeled Monoclonal Antibody Circulation, September 2, 1997; 96(5): 1605 - 1611. [Abstract] [Full Text]

				M Isobe, H Yagita, K Okumura, and A Ihara Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1 Science, February 28, 1992; 255(5048): 1125 - 1127. [Abstract] [PDF]